| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 8459387 | Radiotherapy and Oncology | 2017 | 7 Pages |
Abstract
Radiotherapy showed excellent OS and PFS rates and acceptable late neuroendocrine toxicity profile in this population of LGG patients treated over a period of 13Â years. In our experience, the dose to the HPA was predictive of the risk of late endocrine toxicity.
Related Topics
Life Sciences
Biochemistry, Genetics and Molecular Biology
Cancer Research
Authors
Deborah Aloi, Liliana Belgioia, Salvina Barra, Flavio Giannelli, Francesca Cavagnetto, Fabio Gallo, Claudia Milanaccio, MariaLuisa Garrè, Sonia Di Profio, Natascia Di Iorgi, Renzo Corvò,